What happened
According to a February 18, 2026, SEC filing, Nalanda India Equity Fund Ltd increased its holding in Genpact (G 0.86%) by 1,015,556 shares. The estimated value of this purchase, based on the average share price during the filing quarter, was $43.92 million. The quarter-end value of the position rose by $109.55 million, a figure that reflects both the new shares acquired and changes in Genpact’s share price over the period.
What else to know
The fund executed a buy, increasing its position in Genpact, which is 100% of its 13F reportable assets under management.
Top holdings after the filing:
- NYSE:G: $641.0 million (100% of AUM)
As of February 18, 2026, shares of Genpact were priced at $39.18, down 27.3% over the past year, underperforming the S&P 500 by 39.53 percentage points.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $5.08 billion |
| Net income (TTM) | $552.49 million |
| Dividend yield | 1.74% |
| Price (as of market close 2/18/26) | $39.18 |
Company snapshot
- Genpact provides business process outsourcing, finance and accounting, supply chain, procurement, IT, and digital transformation services across multiple sectors.
- It operates a service-based model, offering recurring business process outsourcing and IT services to enterprise clients across segments.
- The company serves global corporations in banking, capital markets, insurance, consumer goods, healthcare, manufacturing, and high-tech industries.
Genpact is a global provider of information technology and business process outsourcing services, with a focus on large enterprise customers. The company leverages digital solutions and process expertise to drive operational efficiency and transformation for clients across diverse industries.
Its scale, domain knowledge, and diversified client base underpin its competitive positioning in the IT services sector.
What this transaction means for investors
Singapore-based Nalanda India Equity Fund’s purchase of additional shares in Genpact indicates a bullish outlook towards the stock, especially since it is the fund’s only holding.
Shares reached a 52-week low of $34.79 on Feb. 12, which may have sparked Nalanda’s decision to increase its stake. Investors dumped the stock on concerns artificial intelligence would eventually render Genpact’s business obsolete.
Despite this sentiment, the reality is that Genpact is doing well. It exited 2025 with sales of $5.1 billion, a 7% year-over-year increase.
The company expects to deliver another 7% in year-over-year revenue growth in 2026, as it assists businesses to navigate the adoption of AI. This suggests the advent of artificial intelligence is helping, not hindering, Genpact’s business.
But the sell-off in its stock has resulted in its valuation reaching a compelling level. Its price-to-earnings ratio of 12 is the lowest it’s been in a year, making now a good time to buy shares.
